InvestorsHub Logo
Followers 14
Posts 2462
Boards Moderated 0
Alias Born 12/17/2004

Re: None

Tuesday, 06/12/2018 4:13:04 AM

Tuesday, June 12, 2018 4:13:04 AM

Post# of 373
There is No substitutes for experience. From experience we learn, and if we are smart we make contacts to make our present and future experiences easier. If your standards of performance are high and breeds success then colleagues gain confidence in your abilities. It is always easier to believe in someone with a tract record of accomplishes and is the primary reason why I invested in RavenQuest. AJMO and worth what you paid for it.
D


“Ryan
May 9th, 2018

Exclusive, News, Top News

Canada’s cannabis industry is projected to reach C$22.6 billion over the coming years, according to Deloitte, driven by the legalization of adult-use cannabis nationwide. While there are over 100 licensed producers planning to have over 700,000 kilograms of production capacity online by the end of the year, Marijuana Policy Group estimates that demand could exceed 900,000 kilograms and there could be a shortfall in supply.

Investors looking to capitalize on these supply and demand economics have many options, but the best opportunities are companies with strong management teams focused on a niche market that won’t be eroded by the commoditization of the industry over time.

RavenQuest BioMed Inc. (CSE: RQB) began as a management and consulting firm that helped nearly 60 clients become licensed producers of medical cannabis under Health Canada’s ACMPR program. After taking the time to understand their problems, the company partnered with McGill University and began researching technology solutions and began pursuing partnerships that leverage its public company status to finance projects.

CFN Media recently sat down with CEO George Robinson to discuss the company’s approach to the market and why investors may want to take note:”